Can I read Superparamagnetic iron oxide MION as a contrast agent for sodium MRI in myocardial infarction on EtoBox?

Superparamagnetic iron oxide MION as a contrast agent for sodium MRI in myocardial infarction by Chris D. Constantinides; J. Rogers; D.A. Herzka; F.E. Boada; D. Bolar; D. Kraitchman; J. Gillen; P.A. Bottomley is a Medicine article available to read on EtoBox.

What is Superparamagnetic iron oxide MION as a contrast agent for sodium MRI in myocardial infarction about?

## Abstract An intravascular iron‐based contrast agent was used as a sodium (^23^Na) MRI __T__~2~ relaxant in an effort to suppress the blood signal from the ventricular cavities in normal and infarcted canine myocardium in vivo. ^23^Na MRI signal decreases in blood were attributed to decreases in the fast (__T__~2f~) and slow (__T__~2s~) transverse relaxation components, which were quantified as a function of dose and MRI echo time (TE). In vivo ^23^Na MRI signal decreases up to 65% were noted in ventricular blood when imaging under dose and TE conditions of 10 mg/kg body weight and 5 ms, respectively. Contrast injection followed by subsequent ^23^Na MRI in canine myocardial infarction led to a clear delineation of the location of the injured tissue, as identified by postmortem triphenyltetrazolium chloride staining, and to an improvement in the contrast‐to‐noise ratio between the blood in the ventricular chamber and the infarcted tissue that was as high as 3.3‐fold in the postcontrast images in comparison to the precontrast images. Magn Reson Med 46:1164–1168, 2001. © 2001 Wiley‐Liss, Inc.

Who reads Superparamagnetic iron oxide MION as a contrast agent for sodium MRI in myocardial infarction?

Author

Chris D. Constantinides; J. Rogers; D.A. Herzka; F.E. Boada; D. Bolar; D. Kraitchman; J. Gillen; P.A. Bottomley

Publisher

John Wiley and Sons; Wiley (John Wiley & Sons); John Wiley & Sons Inc.; Wiley (ISSN 0740-3194)

Published

2001

Language

EN

Field

Medicine (Health Sciences)